Endomysial Antibody, IgG
Not recommended as an initial test to evaluate for suspected celiac disease (CD). The preferred test to screen for CD is Celiac Disease Reflexive Cascade, Serum (3016817).
New York DOH Approval Status
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.15 mL)
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
Semi-Quantitative Indirect Fluorescent Antibody
Effective November 14, 2011
Less than 1:10
The presence of endomysial antibodies IgG, may be useful in identifying IgA-deficient patients at risk for celiac disease. To establish the diagnosis of celiac disease, a positive result must be confirmed through a biopsy of the small intestine.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|2005502||Endomysial Antibody, IgG||51699-7|
- Anti-Endomysial Antibodies
- EMA IgG
- Gluten-Sensitive Enteropathy Tests
- IgA Deficient Celiac Disease